Ascendis Pharma (ASND) Ownership - Who Owns Ascendis Pharma?

706 Followers

Ascendis Pharma (ASND) Ownership Overview

<0.01% Insiders

11.59% Mutual Funds

2.21% ETFs

86.20% Public Companies and

Individual Investors

The ownership structure of Ascendis Pharma (ASND) stock is a mix of institutional, retail, and individual investors. , <0.01% is owned by Insiders, and 86.20% is owned by Public Companies and Individual Investors.

The ownership structure of Ascendis Pharma (ASND) stock is a mix of institutional, retail, and individual investors. Approximately 13.80% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders, and 86.20% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 01, 2026	Jean Jacques Bienaime	xxxxxxxxxxxxx	$111562
May 27, 2026	Jean Jacques Bienaime	xxxxxxxxxxxxx	$95118

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Perceptive Advisors Llc	xxxxxxxxxxxxx	$350281925
Mar 31, 2024	Driehaus Capital Management Llc	xxxxxxxxxxxxx	$29177256
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$23437734
Mar 31, 2024	Hussman Strategic Advisors Inc	xxxxxxxxxxxxx	$1921332

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Peter Kolchinsky	10,281,496	Institution	16.48%	2,373,277,722
Joseph Edelman	1,531,421	Institution	2.46%	353,497,909
	1,279,738	Institution	2.05%	295,401,923
	1,103,469	Institution	1.77%	254,713,749
	965,222	Institution	1.55%	222,802,194
	740,625	Institution	1.19%	170,958,469
	664,000	Institution	1.06%	153,271,120
	531,184	Institution	0.85%	122,613,203
	440,045	Institution	0.71%	101,575,587
	366,513	Institution	0.59%	84,602,196

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,279,738	Institution	2.05%	295,401,923
1,103,469	Institution	1.77%	254,713,749
965,222	Institution	1.55%	222,802,194
740,625	Institution	1.19%	170,958,469
664,000	Institution	1.06%	153,271,120
531,184	Institution	0.85%	122,613,203
303,835	Institution	0.49%	70,134,233
254,766	Institution	0.41%	58,807,636
216,326	Institution	0.35%	49,934,531
214,582	Institution	0.34%	49,531,963

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
T. Rowe Price Capital Appreciation Equity ETF	342,932	Institution	0.55%	79,268,732
iShares Biotechnology ETF	335,825	Institution	0.54%	77,518,485
Sapient Quality Select ETF	148,246	Institution	0.24%	34,267,063
SPDR Portfolio Developed World ex-US ETF	60,463	Institution	0.10%	13,976,022
iShares NASDAQ US Biotechnology UCITS ETF	46,214	Institution	0.07%	10,667,578
American Century Focused Dynamic Growth ETF	45,563	Institution	0.07%	10,421,625
ARS Focused Opportunity Strategy ETF	38,717	Institution	0.06%	8,949,435
Invesco NASDAQ Next Gen 100 ETF	32,224	Institution	0.05%	7,438,266
Harbor Health Care ETF	28,687	Institution	0.05%	6,621,820
Morgan Stanley Pathway Small-Mid Cap Equity ETF	28,653	Institution	0.05%	6,613,972

FAQ

Who Owns Ascendis Pharma A/S (ASND)?

Currently, no data Available

What percentage of Ascendis Pharma A/S (ASND) stock is held by institutional investors?

Currently, no data Available

What percentage of Ascendis Pharma A/S (ASND) stock is held by retail investors?

According to the latest TipRanks data, approximately 86.20% of Ascendis Pharma A/S (ASND) stock is held by retail investors.

Who owns the most shares of Ascendis Pharma A/S (ASND)?

Peter Kolchinsky owns the most shares of Ascendis Pharma A/S (ASND).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.